Fenfluramine Augmentation of Clomipramine Treatment of Obsessive Compulsive Disorder

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Australian and New Zealand journal of psychiatry (Print)

• Publication date

  1991-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3109/00048679109062643PMID 1958165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PET imaging in obsessive compulsive disorder with and without depression.

  1990cited by this paper
• Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.

  1990cited by this paper
• Signs of central nervous system dysfunction in obsessive-compulsive disorder.

  1990cited by this paper
• Clomipramine in obsessive-compulsive disorder.

  1990cited by this paper
• Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.

  1989cited by this paper
• BRIEF REPORTS: Fluoxetine Treatment of Obsessive‐Compulsive Disorder An Open Clinical Trial

  1989cited by this paper
• Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

  1989cited by this paper
• Clomipramine in Obsessive-Compulsive Disorder: Further Evidence for a Serotonergic Mechanism of Action

  1989cited by this paper
• Open trial of fluoxetine in obsessive-compulsive disorder.

  1989cited by this paper
• Obsessive—Compulsive Disorder as a 5-HT Subsystem-Related Behavioural Disorder

  1989cited by this paper
• Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings.

  1988cited by this paper
• The epidemiology of obsessive-compulsive disorder in five US communities.

  1988cited by this paper
• Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography.

  1988cited by this paper
• Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.

  1987cited by this paper
• d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat.

  1986cited by this paper
• Clomipramine in obsessive-compulsive disorder: a review.

  1983cited by this paper
• The psychopharmacological treatment of obsessive-compulsive disorder: a review.

  1981cited by this paper
• Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine.

  1976cited by this paper
• The mechanism of action of fenfluramine.

  1975cited by this paper
• After-Results of Gassing and Gunshot-wound Chest, especially in Relation to Tuberculosis1

  1929cited by this paper

• Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats.

  2019cites this paper
• REVIEW EFFECTIVENESS OF PSYCHOLOGICAL AND PHARMACOLOGICAL TREATMENTS FOR OBSESSIVE- COMPULSIVE DISORDER: A QUALITATIVE REVIEW

  2011cites this paper
• The effect of clomipramine on wake/sleep and orexinergic expression in rats

  2009cites this paper
• An update on the pharmacological treatment of obsessive-compulsive disorder

  2007cites this paper
• Obsessive-compulsive disorder

  2006cites this paper
• Management of Treatment Refractory Obsessive - Compusive Disorder

  2005cites this paper
• Pharmacotherapeutic Strategy for Obsessive-Compulsive Disorder

  2005cites this paper
• Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder

  2004cites this paper
• 114 CURRENT AND EXPERIMENTAL THERAPEUTICS OF OCD

  2002cites this paper
• Pharmacological management of obsessive-compulsive disorder: a review for clinicians.

  2002cites this paper
• Pharmacotherapy of anxious disorders

  2002influential citation
• Management of treatment resistant obsessive-compulsive disorder. Algorithms for pharmacotherapy.

  2002cites this paper
• Pharmacotherapy for obsessive-compulsive disorder.

  2000cites this paper
• Update on pharmacologic management of OCD: agents and augmentation.

  1997cites this paper
• Treatment of obsessive compulsive disorder: Algorithms for pharmacotherapy.

  1997cites this paper
• Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

  1997cites this paper
• A Risk-Benefit Assessment of Drugs Used in the Management of Obsessive-Compulsive Disorder

  1996cites this paper
• Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies.

  1994cites this paper
• Management of treatment-refractory obsessive compulsive disorder patients.

  1994cites this paper
• Fenfluramine and trichotillomania.

  1993cites this paper
• Biological approaches to treatment-resistant obsessive compulsive disorder.

  1993cites this paper
• Augmentation Strategies for Treatment‐Resistant Obsessive‐Compulsive Disorder*

  1993cites this paper
• Buspirone and Fluoxetine in the Treatment of OCD

  1992cites this paper